For the quarter ending 2026-03-31, IVVD had -$42,536K decrease in cash & cash equivalents over the period. -$42,438K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -41,400 | -11,070 | -10,470 | -30,949 |
| Stock-based compensation expense | 2,697 | 2,564 | 3,073 | 6,006 |
| Amortization of operating lease right-of-use assets | 345 | 286 | 282 | 784 |
| Depreciation and amortization expense | 168 | 149 | 149 | 457 |
| Other non-cash adjustments | -54 | -2 | -205 | -91 |
| Accounts receivable | -2,221 | 4,068 | 1,360 | -2,091 |
| Inventory | -47 | 352 | -50 | 71 |
| Prepaid expenses and other current assets | 2,123 | -7,565 | -562 | -4,797 |
| Other non-current liabilities | - | 0 | 0 | 0 |
| Other non-current assets | 1,046 | 105 | -10 | -18 |
| Deferred revenue | - | - | - | 0 |
| Accounts payable | -11,566 | -4,246 | -218 | 7,675 |
| Accrued expenses | 9,184 | -6,016 | -251 | -24,580 |
| Operating lease liabilities | -297 | -182 | -289 | -747 |
| Other current liabilities | 4 | 18 | 7 | -2 |
| Net cash used in operating activities | -41,712 | -15,455 | -8,250 | -34,430 |
| Purchases of property and equipment | 726 | 0 | 0 | 155 |
| Net cash used in investing activities | -726 | 0 | 0 | -155 |
| Proceeds from exercises of stock options | 74 | 306 | 0 | 105 |
| Proceeds from issuance of common stock under the employee stock purchase plan | 135 | 76 | 56 | 122 |
| Proceeds from at-the-market offering, net of commissions | - | 28,916 | 4,484 | - |
| Proceeds from underwritten public offering, net of underwriting discounts and commissions | - | 128,486 | 54,048 | - |
| Proceeds from issuance of common stock, net of issuance costs | - | - | - | 0 |
| Payments for at-the-market offering costs | 76 | 191 | 145 | - |
| Payments for offering costs | - | - | - | 86 |
| Payments for underwritten public offering costs | 231 | 416 | 217 | - |
| Net cash (used in) provided by financing activities | -98 | 157,177 | 58,312 | 141 |
| Effect of exchange rate changes on cash and cash equivalents | 0 | 0 | - | - |
| Net decrease in cash and cash equivalents | -42,536 | 141,722 | 50,062 | -34,444 |
| Cash and cash equivalents at beginning of period | 226,689 | 84,967 | 69,349 | - |
| Cash and cash equivalents at end of period | 184,153 | 226,689 | 84,967 | - |
Invivyd, Inc. (IVVD)
Invivyd, Inc. (IVVD)